Protein kinase D1 overexpression potentiates epidermal growth factor signaling pathway in MCF-7 cells

Mol Biol Rep. 2023 Apr;50(4):3641-3651. doi: 10.1007/s11033-023-08300-z. Epub 2023 Feb 17.

Abstract

Background: Protein kinase D1, PKD1, is a serine-threonine kinase implicated in cell proliferation, migration, invasion, and/or apoptosis and its activation by several growth factors sets this enzyme as a key regulator of tumorigenesis and tumor progression. Despite many studies, its role in the regulation of intracellular signaling pathways remains widely disparate and needs to be clarified.

Methods and results: By using human breast cancer cells MCF-7, overexpressing or not PKD1, we demonstrated that PKD1 expression level modulated the tumor growth-promoting epidermal growth factor (EGF) signaling pathway. We also showed that EGF acutely stimulated PKD1 phosphorylation with similar time courses both in control and PKD1-overexpressing cells. However, PKD1 overexpression specifically and markedly increased EGF-induced phosphorylation of Akt (onto T308 and S473 residues) and extracellular-regulated protein kinase (ERK1/2). Finally, pharmacological inhibition of PKD1 activity or lowering its expression level using specific siRNAs drastically reduced EGF-stimulated Akt and ERK phosphorylation in PKD1overexpressing cells, but not in control cells.

Conclusions: Overall, these results identified the level of PKD1 expression as a key determinant in the regulation of the EGF signaling pathway highlighting its crucial role in a tumorigenic setting.

Keywords: Breast cancer cell; Cell signaling; Epidermal growth factor; Protein kinase D1.

MeSH terms

  • Epidermal Growth Factor* / metabolism
  • Epidermal Growth Factor* / pharmacology
  • Humans
  • MAP Kinase Signaling System
  • MCF-7 Cells
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt* / metabolism
  • Signal Transduction

Substances

  • Epidermal Growth Factor
  • Proto-Oncogene Proteins c-akt